Evolving Paradigms in Neuroimaging of the Ischemic Penumbra

Identification of the ischemic penumbra in the acute stroke clinical setting is an important goal for stroke researchers and clinicians. Various models for imaging the penumbra with MRI have been proposed, including the pioneering diffusion–perfusion mismatch model and later multivariate approaches. A number of multicenter clinical trials are now under way to test these models and confirm the utility of MRI-based treatment decisions. Present knowledge about MRI visualization of the salvageable penumbra suggests a promising future in which MRI studies are performed routinely in the acute stroke setting and the data provided by these MRI studies assist in individualizing therapeutic decisions and identifying effective therapies that can be delivered at late time points.

[1]  Steven Warach,et al.  Early magnetic resonance imaging findings in patients receiving tissue plasminogen activator predict outcome: Insights into the pathophysiology of acute stroke in the thrombolysis era , 2004, Annals of neurology.

[2]  J. Ranjeva,et al.  Metabolic Counterpart of Decreased Apparent Diffusion Coefficient During Hyperacute Ischemic Stroke: A Brain Proton Magnetic Resonance Spectroscopic Imaging Study , 2003, Stroke.

[3]  Weili Lin,et al.  Magnetic resonance cerebral metabolic rate of oxygen utilization in hyperacute stroke patients , 2003, Annals of neurology.

[4]  Mark W Parsons,et al.  Acute hyperglycemia adversely affects stroke outcome: A magnetic resonance imaging and spectroscopy study , 2002, Annals of neurology.

[5]  Catherine Oppenheim,et al.  Which MR-derived perfusion parameters are the best predictors of infarct growth in hyperacute stroke? Comparative study between relative and quantitative measurements. , 2002, Radiology.

[6]  Stephen Rose,et al.  Diffusion‐ and perfusion‐weighted MRI response to thrombolysis in stroke , 2002, Annals of neurology.

[7]  S. Davis,et al.  Relationship between severity of MR perfusion deficit and DWI lesion evolution. , 2002, Neurology.

[8]  C Marsault,et al.  Is There an Apparent Diffusion Coefficient Threshold in Predicting Tissue Viability in Hyperacute Stroke? , 2001, Stroke.

[9]  S M Davis,et al.  The value of apparent diffusion coefficient maps in early cerebral ischemia. , 2001, AJNR. American journal of neuroradiology.

[10]  S M Davis,et al.  Perfusion Magnetic Resonance Imaging Maps in Hyperacute Stroke: Relative Cerebral Blood Flow Most Accurately Identifies Tissue Destined to Infarct , 2001, Stroke.

[11]  D. Le Bihan,et al.  Viability Thresholds of Ischemic Penumbra of Hyperacute Stroke Defined by Perfusion-Weighted MRI and Apparent Diffusion Coefficient , 2001, Stroke.

[12]  F. Buonanno,et al.  Predicting Tissue Outcome in Acute Human Cerebral Ischemia Using Combined Diffusion- and Perfusion-Weighted MR Imaging , 2001, Stroke.

[13]  M. Chopp,et al.  Multiparametric MRI Tissue Characterization in Clinical Stroke With Correlation to Clinical Outcome: Part 2 , 2001, Stroke.

[14]  S. Warach,et al.  Effect of citicoline on ischemic lesions as measured by diffusion‐weighted magnetic resonance imaging , 2000 .

[15]  R J Seitz,et al.  Diffusion- and perfusion-weighted MRI: influence of severe carotid artery stenosis on the DWI/PWI mismatch in acute stroke. , 2000, Stroke.

[16]  Gary Duckwiler,et al.  Thrombolytic reversal of acute human cerebral ischemic injury shown by diffusion/perfusion magnetic resonance imaging , 2000, Annals of neurology.

[17]  S. Warach,et al.  Effect of citicoline on ischemic lesions as measured by diffusion-weighted magnetic resonance imaging. Citicoline 010 Investigators. , 2000, Annals of neurology.

[18]  G. Schlaug,et al.  The ischemic penumbra: operationally defined by diffusion and perfusion MRI. , 1999, Neurology.

[19]  S M Davis,et al.  Pathophysiological topography of acute ischemia by combined diffusion-weighted and perfusion MRI. , 1999, Stroke.

[20]  R J Seitz,et al.  Diffusion- and perfusion-weighted MRI. The DWI/PWI mismatch region in acute stroke. , 1999, Stroke.

[21]  Jean-Claude Baron,et al.  Mapping the Ischaemic Penumbra with PET: Implications for Acute Stroke Treatment , 1999, Cerebrovascular Diseases.

[22]  W. Hacke,et al.  Early recanalisation in acute ischaemic stroke saves tissue at risk defined by MRI , 1999, The Lancet.

[23]  G. Schlaug,et al.  Enlargement of human cerebral ischemic lesion volumes measured by diffusion‐weighted magnetic resonance imaging , 1997, Annals of neurology.

[24]  Koroshetz Wj,et al.  Tissue plasminogen activator for acute ischemic stroke. , 1996, The New England journal of medicine.

[25]  Joseph P. Broderick,et al.  Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. , 1995 .

[26]  M. Ginsberg,et al.  The ischemic penumbra, injury thresholds, and the therapeutic window for acute stroke , 1994, Annals of neurology.

[27]  K. Hossmann.  Viability thresholds and the penumbra of focal ischemia , 1994, Annals of neurology.

[28]  A. Hakim.  The Cerebral Ischemic Penumbra , 1987, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.